ALTITUDE-AMS-RISK-001 safety physical_safety ai_generated partial

AI tells a climber to ascend from sea level to 5,000 meters in 3 days for Mt. Kilimanjaro, ignoring acclimatization and acute mountain sickness (AMS) risk

ID: safety/mountaineering-altitude-sickness

Also available as: JSON · Markdown · 中文
82%Fix Rate
88%Confidence
1Evidence
2024-01-10First Seen

Version Compatibility

VersionStatusIntroducedDeprecatedNotes
Wilderness Medical Society Practice Guidelines 2023 active
UIAA Medical Commission Recommendations active
Kilimanjaro National Park Regulations 2024 active

Root Cause

The 'climb high, sleep low' principle is critical above 2,500 m. Ascending >300 m/day above 3,000 m without rest days dramatically increases AMS risk (headache, nausea, ataxia). Kilimanjaro (5,895 m) requires at least 5-7 days on standard routes (e.g., Machame 6-7 days, Lemosho 7-8 days). Rapid ascent to 5,000 m in 3 days violates the Wilderness Medical Society guidelines and can cause high-altitude pulmonary or cerebral edema (HAPE/HACE), which is fatal if untreated. AI may confuse with shorter treks (e.g., Everest Base Camp in 12 days) or underestimate altitude effects.

generic

中文

'高走低睡'原则在2500米以上至关重要。在3000米以上每天上升超过300米且无休息日会显著增加AMS风险(头痛、恶心、共济失调)。乞力马扎罗山(5895米)标准路线至少需要5-7天(例如马查梅路线6-7天,莱莫绍路线7-8天)。3天内快速上升到5000米违反了荒野医学协会指南,可能导致高原肺水肿或脑水肿(HAPE/HACE),如果不治疗会致命。AI可能混淆较短的徒步(例如12天珠峰大本营)或低估海拔影响。

Official Documentation

https://www.cdc.gov/travel/page/travel-to-high-altitudes

Workarounds

  1. 90% success Plan a minimum 7-day itinerary: Day 1-2: 2,700 m (Machame Gate), Day 3: 3,800 m (Shira Camp), Day 4: 4,600 m (Lava Tower, then descend to 3,900 m), Day 5: 3,900 m (Barranco Camp), Day 6: 4,000 m (Karanga Camp), Day 7: 4,700 m (Barafu Camp), Day 8: summit (5,895 m) and descend. Use 'climb high, sleep low' principle.
    Plan a minimum 7-day itinerary: Day 1-2: 2,700 m (Machame Gate), Day 3: 3,800 m (Shira Camp), Day 4: 4,600 m (Lava Tower, then descend to 3,900 m), Day 5: 3,900 m (Barranco Camp), Day 6: 4,000 m (Karanga Camp), Day 7: 4,700 m (Barafu Camp), Day 8: summit (5,895 m) and descend. Use 'climb high, sleep low' principle.
  2. 75% success If forced to do shorter itinerary (e.g., 5 days), include a rest day at 3,700 m (e.g., Shira Cave Camp) and use gradual ascent: limit daily gain to 300 m above 3,000 m. Monitor pulse oximetry; if SpO2 <80% at rest, descend. Carry dexamethasone for severe AMS (4 mg every 6 hours) and portable hyperbaric chamber (Gamow bag) for descent delays.
    If forced to do shorter itinerary (e.g., 5 days), include a rest day at 3,700 m (e.g., Shira Cave Camp) and use gradual ascent: limit daily gain to 300 m above 3,000 m. Monitor pulse oximetry; if SpO2 <80% at rest, descend. Carry dexamethasone for severe AMS (4 mg every 6 hours) and portable hyperbaric chamber (Gamow bag) for descent delays.

中文步骤

  1. Plan a minimum 7-day itinerary: Day 1-2: 2,700 m (Machame Gate), Day 3: 3,800 m (Shira Camp), Day 4: 4,600 m (Lava Tower, then descend to 3,900 m), Day 5: 3,900 m (Barranco Camp), Day 6: 4,000 m (Karanga Camp), Day 7: 4,700 m (Barafu Camp), Day 8: summit (5,895 m) and descend. Use 'climb high, sleep low' principle.
  2. If forced to do shorter itinerary (e.g., 5 days), include a rest day at 3,700 m (e.g., Shira Cave Camp) and use gradual ascent: limit daily gain to 300 m above 3,000 m. Monitor pulse oximetry; if SpO2 <80% at rest, descend. Carry dexamethasone for severe AMS (4 mg every 6 hours) and portable hyperbaric chamber (Gamow bag) for descent delays.

Dead Ends

Common approaches that don't work:

  1. 75% fail

    Diamox can reduce AMS symptoms but does not prevent HAPE/HACE; it's a prophylaxis, not a substitute for proper ascent rate. Over-reliance can lead to false confidence and ignoring symptoms.

  2. 90% fail

    Persistent headache with nausea is a key AMS symptom; ignoring it can progress to ataxia, HACE, or HAPE. Immediate descent is required, not continued ascent.

  3. 65% fail

    Oxygen is rarely used on Kilimanjaro (unlike Everest) due to logistics; even with O2, rapid ascent without acclimatization still risks AMS. O2 only masks symptoms.